chr6-54308698-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_014464.4(TINAG):āc.148G>Cā(p.Ala50Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000157 in 1,461,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014464.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TINAG | ENST00000259782.9 | c.148G>C | p.Ala50Pro | missense_variant | 1/11 | 1 | NM_014464.4 | ENSP00000259782.4 | ||
TINAG | ENST00000370869.7 | c.136G>C | p.Ala46Pro | missense_variant | 2/6 | 3 | ENSP00000359906.3 | |||
TINAG | ENST00000370864.3 | c.94G>C | p.Ala32Pro | missense_variant | 1/4 | 2 | ENSP00000359901.3 | |||
TINAG | ENST00000486436.1 | n.210G>C | non_coding_transcript_exon_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251128Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135710
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461616Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727120
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.148G>C (p.A50P) alteration is located in exon 1 (coding exon 1) of the TINAG gene. This alteration results from a G to C substitution at nucleotide position 148, causing the alanine (A) at amino acid position 50 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at